| Lineage |
iPSC > Neural Progenitor > Hippocampal Neuron |
| Markers |
PROX1, CALB1, DCX, MAP2, NEUN |
| Brain Regions |
Hippocampus - Dentate Gyrus, CA1, CA3 |
| Disease Relevance |
Alzheimer's Disease, Temporal Lobe Epilepsy, Hippocampal Sclerosis |
Ipsc Derived Hippocampal Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-derived hippocampal neurons are in vitro generated neurons that recapitulate the molecular, morphological, and electrophysiological properties of authentic hippocampal neurons. Derived from human induced pluripotent stem cells (iPSCs) through directed differentiation protocols, these neurons express hippocampal-specific markers including PROX1 (dentate gyrus granule cells), CALB1 (CA1 pyramidal neurons), and exhibit functional synaptic connections[1][2].
Standard protocols use dual-SMAD inhibition (SB431542 and LDN-193189) to guide neural ectoderm induction, followed by patterning toward hippocampal fate using WNT activation and BMP inhibition[^3].
Hippocampal differentiation proceeds through defined stages:
- Days 0-7: Neural ectoderm induction
- Days 7-25: Hippocampal progenitor specification
- Days 25-60: Neuronal differentiation and maturation
- Day 60+: Synapse formation and functional characterization
PROX1-expressing granule cells that form the hippocampal mossy fiber pathway. These neurons are particularly vulnerable in Alzheimer's disease and temporal lobe epilepsy[^4].
The primary excitatory neurons of the CA1 subfield, crucial for hippocampal-dependent learning and memory. These neurons show early synaptic dysfunction in Alzheimer's disease models[^5].
neurons that receive mossy fiber inputs from dentate gyrus granule cells and participate in pattern separation.
iPSC-derived hippocampal neurons from AD patients exhibit:
- Elevated amyloid-beta production and secretion
- Tau hyperphosphorylation and aggregation
- Synaptic marker loss
- Elevated reactive oxygen species
- Mitochondrial dysfunction
Patient-derived neurons model hippocampal sclerosis and reveal neuronal hyperexcitability mechanisms[^6].
- Resting membrane potential: -60 to -70 mV
- Action potential generation in response to current injection
- Spontaneous excitatory postsynaptic currents (sEPSCs)
- GABAergic synaptic inputs develop over maturation
- Patient-specific genetic background enables disease modeling
- Human-relevant biology for drug testing
- Renewable cell source
- Functional synaptic connectivity
- Fetal-like maturation state
- Variable differentiation efficiency
- Lack of glial interactions in monocultures
- Absence of blood-brain barrier
iPSC-derived hippocampal neurons from AD patients provide unique insights:
- APP mutations: Patients with familial AD show increased Aβ42/Aβ40 ratio
- Presenilin mutations: Altered gamma-secretase activity
- Aβ secretion: Elevated extracellular accumulation
- Oligomer formation: Toxic soluble oligomers detected
- Hyperphosphorylation: Increased pTau/total Tau ratio
- Aggregation: Formation of NFTs-like structures
- Axonal transport defects: Tau-mediated microtubule dysfunction
- Tau spreading: Inter-neuronal propagation mechanisms
- Presynaptic markers: Reduced synaptophysin, synapsin
- Postsynaptic markers: Decreased PSD95, NMDA receptors
- Electrophysiology: Impaired LTP, reduced mEPSCs
- Dendritic spines: Morphological abnormalities
- Hyperexcitability: Increased action potential firing
- Aberrant mossy fiber sprouting: Recurrent excitatory connections
- GABAergic dysfunction: Inhibitory neuron deficits
- Cell death: Hippocampal sclerosis phenotypes
- Antiepileptic drug testing: Efficacy in patient-derived neurons
- Precision medicine: Genotype-specific responses
- ** Mechanism of action**: Channel modulators, metabolic agents
| Property |
Value |
Significance |
| Resting potential |
-60 to -70 mV |
Standard neuronal range |
| Input resistance |
1-5 GΩ |
Healthy neuronal membrane |
| Membrane capacitance |
20-50 pF |
Cell size dependent |
- Threshold: -50 to -40 mV
- Amplitude: 80-100 mV
- Duration: 2-5 ms
- Firing pattern: Regular spiking, adapting
- mEPSCs: AMPA receptor-mediated, 10-20 pA
- mIPSCs: GABA receptor-mediated, 20-40 pA
- LTP induction: NMDA receptor-dependent
- Synaptic latency: 2-5 ms
RNA-seq analysis reveals hippocampal neuron signatures:
- Proliferation genes: Ki67, PCNA (progenitors)
- Neuronal genes: MAP2, TUBB3, NEUN
- Hippocampal markers: PROX1, CALB1, WNT2
- Synaptic genes: SNAP25, SYT1, PSD95
| Marker |
Subtype |
Function |
| PROX1 |
Dentate granule |
Transcription factor |
| CALB1 |
CA1 pyramidal |
Calcium binding |
| WNT2 |
Hippocampal pattern |
Development |
| nNOS |
Interneurons |
Nitric oxide |
iPSC-derived hippocampal neurons enable:
- Target validation: Confirm mechanism of action
- Toxicity screening: Off-target effects
- Efficacy testing: Disease modification
- Patient stratification: Genetic subtypes
| Trial Phase |
Application |
| Preclinical |
Target engagement |
| Phase I |
Safety pharmacology |
| Phase II |
Biomarker development |
| Phase III |
Patient selection |
¶ Challenges and Limitations
- Adult-like properties: May require extended culture (6-12 months)
- Epigenetic memory: Donor cell type influence
- Variability: Line-to-line differences
- Late-onset diseases: Age-related mechanisms difficult to model
- Aβ accumulation: May require overexpression systems
- Tau pathology: Often requires multiple mutations
The study of Ipsc Derived Hippocampal Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Takahashi et al., Induction of pluripotent stem cells from adult human fibroblasts (2007)
- Yu et al., Induced pluripotent stem cells from human blood (2009)
- Chambers et al., Highly efficient neural conversion of human ESCs (2009)
- Palop et al., Network dysfunction in Alzheimer's disease (2012)
- Kelley & Benakis, Alzheimer's disease in a dish (2017)
- Yu et al., Efficient generation of hippocampal neurons from human pluripotent stem cells (2014)
- Sarkar et al., Efficient and stable conversion of iPSCs to hippocampal neurons (2018)
- Braham et al., Human hippocampal neurogenesis after traumatic brain injury (2020)
- Palmer et al., Neurogenesis in the adult hippocampus (2019)
- Tremblay et al., Synaptic pathology in Alzheimer's disease (2017)
- Sabbagh et al., iPSC models of epilepsy (2019)